Skip to contentBAKER JULIAN — INCYTE CORP insider: 1,455 transactions · InsiderLensBAKER JULIAN
- 10% owner at IDERA PHARMACEUTICALS, INC. · on record since Mar 29, 2006
- Member at IDERA PHARMACEUTICALS, INC. · on record since Mar 28, 2006
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Feb 28, 2006
- Director at SYNTA PHARMACEUTICALS CORP · on record since Jun 20, 2023
- Director at NEUROGEN CORP · on record since Mar 16, 2006
- 10% owner at NEUROGEN CORP · on record since Mar 16, 2006
- 10% owner at VIROPHARMA INC · on record since Mar 1, 2006
- Former 10% Owner at Atreca, Inc. · on record since Oct 23, 2023
- 10% owner at SEATTLE GENETICS INC /WA · on record since Jun 29, 2006
- 10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since Apr 28, 2006
- Director at TRIMERIS INC · on record since Apr 28, 2006
- 10% owner at TRIMERIS INC · on record since Apr 28, 2006
- Director at GENOMIC HEALTH INC · on record since Apr 28, 2006
- Director at INCYTE CORP · on record since Apr 28, 2006
- Director at THERAVANCE INC · on record since Apr 28, 2006
- Former 10% Owner at Neurogene Inc. · on record since Dec 20, 2023
- Former 10% Owner at SEATTLE GENETICS INC /WA · on record since Dec 18, 2023
- Director at SEATTLE GENETICS INC /WA · on record since Jun 13, 2006
- 10% owner at Mirati Therapeutics, Inc. · on record since Oct 28, 2013
- 10% owner at ALLOS THERAPEUTICS INC · on record since Nov 30, 2006
- Director at vTv Therapeutics Inc. · on record since Mar 7, 2024
- Director at Immunocore Holdings plc · on record since May 29, 2024
- Director at BICYCLE THERAPEUTICS PLC · on record since May 29, 2024
- 10% owner at BICYCLE THERAPEUTICS PLC · on record since May 29, 2024
- 10% owner at Kala Pharmaceuticals, Inc. · on record since Jun 28, 2024
- Director at Kymera Therapeutics, Inc. · on record since Apr 1, 2024
- 10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Mar 11, 2010
- 10% owner at GENOMIC HEALTH INC · on record since Feb 21, 2007
- Director at TScan Therapeutics, Inc. · on record since May 22, 2026
- 10% owner at SERA PROGNOSTICS, INC. · on record since Feb 14, 2025
- 10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 8, 2007
- 10% owner at ALTEON INC /DE · on record since Aug 3, 2007
- 10% owner at INCYTE CORP · on record since Dec 19, 2007
- Former 10% owner and director at IGM Biosciences, Inc. · on record since Aug 18, 2025
- 10% owner at Celcuity Inc. · on record since Sep 10, 2025
- 10% owner at Kymera Therapeutics, Inc. · on record since Dec 11, 2025
- Former 10% owner at Kala Pharmaceuticals, Inc. · on record since Oct 2, 2025
- 10% owner at AP PHARMA INC /DE/ · on record since Oct 28, 2009
- 10% owner at ADOLOR CORP · on record since Apr 28, 2010
- Director at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Apr 8, 2010
- 10% owner at VAXGEN INC · on record since Jul 29, 2010
- Director at Replimune Group, Inc. · on record since Apr 7, 2026
- 10% owner at Replimune Group, Inc. · on record since Apr 7, 2026
- 10% owner at PHARMACYCLICS INC · on record since Aug 24, 2011
- Director at BeOne Medicines Ltd. · on record since May 27, 2026
- Director at Prelude Therapeutics Inc · on record since Apr 22, 2026
- 10% owner at Prelude Therapeutics Inc · on record since Apr 22, 2026
- 10% owner at TRANZYME INC · on record since Mar 14, 2012
- 10% owner at XOMA LTD /DE/ · on record since Mar 8, 2012
- Director at XOMA LTD /DE/ · on record since Oct 31, 2012
- 10% owner at ACADIA PHARMACEUTICALS INC · on record since Dec 21, 2012
- Director at ACADIA PHARMACEUTICALS INC · on record since Jan 23, 2013
- 10% owner at MAYTAG CORP · on record since Jul 11, 2013
- Director at IDERA PHARMACEUTICALS, INC. · on record since Mar 19, 2014
- Director at Kiniksa Pharmaceuticals International, plc · on record since Jun 2, 2026
- Director at Denali Therapeutics Inc. · on record since Jun 5, 2026
- Director at ALEXION PHARMACEUTICALS INC · on record since Jun 30, 2015
- Former 10% owner and Director at TRIMERIS INC · on record since Jun 23, 2015
- 10% owner at Invitae Corp · on record since Aug 27, 2015
- Former 10% owner at XOMA LTD /DE/ · on record since Jul 23, 2015
- 10% owner at Neurogene Inc. · on record since Sep 11, 2015
- 10% owner at BELLICUM PHARMACEUTICALS, INC · on record since Dec 24, 2015
- 10% owner at BeOne Medicines Ltd. · on record since Feb 9, 2016
- Former 10% owner at Intellia Therapeutics, Inc. · on record since May 11, 2016
- 10% owner at Intellia Therapeutics, Inc. · on record since May 5, 2016
- Director at Neurogene Inc. · on record since May 9, 2017
- Former 10% Owner at Mirati Therapeutics, Inc. · on record since Nov 20, 2017
- Former 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 6, 2017
- 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 4, 2017
- 10% owner at Kiniksa Pharmaceuticals International, plc · on record since May 31, 2018
- 10% owner at Principia Biopharma Inc. · on record since Sep 13, 2018
- Director at Kodiak Sciences Inc. · on record since Oct 11, 2018
- 10% owner at Kodiak Sciences Inc. · on record since Oct 11, 2018
- 10% owner at Atreca, Inc. · on record since Jun 26, 2019
- Former 10% owner at REDHOOK ALE BREWERY INC · on record since Apr 23, 2019
- 10% owner at REDHOOK ALE BREWERY INC · on record since Apr 18, 2019
- Director at IGM Biosciences, Inc. · on record since Sep 20, 2019
- 10% owner at IGM Biosciences, Inc. · on record since Sep 20, 2019
- Director at SMI PRODUCTS INC · on record since Dec 20, 2019
- 10% owner at SMI PRODUCTS INC · on record since Oct 15, 2019
- Director at Zymeworks Inc. · on record since Mar 16, 2020
- Director at Spyre Therapeutics, Inc. · on record since Feb 25, 2021
- Director at Talis Biomedical Corp · on record since Feb 19, 2021
- 10% owner at Talis Biomedical Corp · on record since Feb 19, 2021
- Director at DBV Technologies S.A. · on record since Jan 11, 2021
- 10% owner at DBV Technologies S.A. · on record since Jan 11, 2021
- 10% owner at TScan Therapeutics, Inc. · on record since Jul 15, 2021
- 10% owner at Entrada Therapeutics, Inc. · on record since Dec 16, 2021
Insider trading activity of BAKER JULIAN
- Transactions on record
- 1,455
- since Apr 27, 2004
- Open-market buys
- 801
- $679M
- Open-market sells
- 181
- $115.5M
- Companies traded
- 36
- last filing Jan 14, 2026
Figures computed from official regulatory filings — methodology.
Companies where BAKER JULIAN has traded
- DBV Technologies S.A.4 tx · Jan 14, 2026
- Denali Therapeutics Inc.2 tx · $40M · Dec 15, 2025
- Kala Pharmaceuticals, Inc.4 tx · $1.1M · Oct 2, 2025
- vTv Therapeutics Inc.6 tx · Sep 5, 2025
- Kiniksa Pharmaceuticals International, plc9 tx · Jun 5, 2025
- BICYCLE THERAPEUTICS PLC2 tx · $366.6M · May 29, 2024
- IGM Biosciences, Inc.10 tx · $105M · Mar 14, 2024
- SYNTA PHARMACEUTICALS CORP26 tx · $269.9M · Nov 21, 2023
- Atreca, Inc.4 tx · $12.6M · Oct 23, 2023
Track record of BAKER JULIAN
Statistical track record
Free- Open-market buys
- 872
- Last buy
- Dec 11, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of BAKER JULIAN
Co-insiders of BAKER JULIAN
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
12 tx · $150.1M · Jun 5, 2023
Neu KelvinIGM Biosciences, Inc. +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jan 14, 2026 | ExerciseD | -25,005,240 | 0.00 USD | $0 | SEC |
| Jan 14, 2026 | ExerciseD | 2,299,656 | 0.00 USD | $0 | SEC |
| Jan 14, 2026 | ExerciseD | 25,005,240 | 0.00 USD | $0 | SEC |
| Jan 14, 2026 | ExerciseD | -2,299,656 | 0.00 USD | $0 | SEC |
| Dec 15, 2025 | BuyD | 190,523 | 17.49 USD | $3.3M | SEC |
| Dec 15, 2025 | BuyD | 2,095,191 | 17.49 USD | $36.6M | SEC |
| Oct 2, 2025 | Sell | -462,967 | 1.38 USD | $638.9K | SEC |
| Oct 2, 2025 | Sell | -50,640 | 1.38 USD | $69.9K | SEC |
| Oct 2, 2025 | Sell | -21,376 | 1.60 USD | $34.2K | SEC |
| Oct 2, 2025 | Sell | -195,425 | 1.60 USD | $312.7K | SEC |
| Sep 5, 2025 | AwardD | 217,144 | — | — | SEC |
| Sep 5, 2025 | AwardD | 2,353,913 | — | — | SEC |
| Sep 5, 2025 | AwardD | 2,400,605 | — | — | SEC |
| Sep 5, 2025 | Award | 46,692 | — | — | SEC |
| Sep 5, 2025 | Award | 4,308 | — | — | SEC |
| Sep 5, 2025 | AwardD | 221,452 | — | — | SEC |
| Jun 5, 2025 | AwardD | 50,394 | 0.00 USD | $0 | SEC |
| Jun 5, 2025 | Award | 8,397 | 0.00 USD | $0 | SEC |
| Jun 5, 2025 | AwardD | 50,394 | 0.00 USD | $0 | SEC |
| Jun 5, 2025 | Award | 8,397 | 0.00 USD | $0 | SEC |
| Jun 7, 2024 | AwardD | 38,080 | 0.00 USD | $0 | SEC |
| Jun 7, 2024 | Award | 6,346 | 0.00 USD | $0 | SEC |
| Jun 7, 2024 | AwardD | 38,080 | 0.00 USD | $0 | SEC |
| Jun 7, 2024 | Award | 6,346 | 0.00 USD | $0 | SEC |
| May 29, 2024 | AwardD | 1,429,986 | 21.42 USD | $30.6M | SEC |